Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen plus ultraviolet A for the treatment of plaque-type psoriasis using the …
SP Sivanesan, S Gattu, J Hong… - Journal of the American …, 2009 - Elsevier
BACKGROUND: Psoralen plus ultraviolet A (PUVA) for the treatment of psoriasis has never
been evaluated using the Psoriasis Area Severity Index (PASI) in a randomized, double …
been evaluated using the Psoriasis Area Severity Index (PASI) in a randomized, double …
Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen plus ultraviolet A for the treatment of plaque-type psoriasis using the …
SP Sivanesan, S Gattu, J Hong… - Journal of the American …, 2009 - jaad.org
Background Psoralen plus ultraviolet A (PUVA) for the treatment of psoriasis has never been
evaluated using the Psoriasis Area Severity Index (PASI) in a randomized, double-blind …
evaluated using the Psoriasis Area Severity Index (PASI) in a randomized, double-blind …
Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen plus ultraviolet A for the treatment of plaque-type psoriasis using the …
SP Sivanesan, S Gattu, J Hong… - Journal of the …, 2009 - europepmc.org
Background Psoralen plus ultraviolet A (PUVA) for the treatment of psoriasis has never been
evaluated using the Psoriasis Area Severity Index (PASI) in a randomized, double-blind …
evaluated using the Psoriasis Area Severity Index (PASI) in a randomized, double-blind …
Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen plus ultraviolet A for the treatment of plaque-type psoriasis using the …
SP Sivanesan, S Gattu, J Hong… - Journal of the American …, 2009 - infona.pl
Psoralen plus ultraviolet A (PUVA) for the treatment of psoriasis has never been evaluated
using the Psoriasis Area Severity Index (PASI) in a randomized, double-blind, placebo …
using the Psoriasis Area Severity Index (PASI) in a randomized, double-blind, placebo …
[引用][C] Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen plus ultraviolet A for the treatment of plaque-type psoriasis using the …
SP SIVANESAN, S GATTU, J HONG… - Journal of the …, 2009 - pascal-francis.inist.fr
Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen
plus ultraviolet A for the treatment of plaque-type psoriasis using the Psoriasis Area Severity …
plus ultraviolet A for the treatment of plaque-type psoriasis using the Psoriasis Area Severity …
Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen plus ultraviolet A for the treatment of plaque-type psoriasis using the …
SP Sivanesan, S Gattu, J Hong, A Chavez-Frazier… - 2009 - pubmed.ncbi.nlm.nih.gov
Background Psoralen plus ultraviolet A (PUVA) for the treatment of psoriasis has never been
evaluated using the Psoriasis Area Severity Index (PASI) in a randomized, double-blind …
evaluated using the Psoriasis Area Severity Index (PASI) in a randomized, double-blind …
Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen plus ultraviolet A for the treatment of plaque-type psoriasis using the …
SP Sivanesan, S Gattu, J Hong… - Journal of the American …, 2009 - infona.pl
Psoralen plus ultraviolet A (PUVA) for the treatment of psoriasis has never been evaluated
using the Psoriasis Area Severity Index (PASI) in a randomized, double-blind, placebo …
using the Psoriasis Area Severity Index (PASI) in a randomized, double-blind, placebo …